Meta-analysis of 5 RCTs (721,607 participants, 11-23 years' follow-up): PSA-based screening vs no screening or usual care reduced prostate cancer-specific mortality at longest follow-up (high-certainty evidence), with greater reduction at longer follow-up.
Meta-analysisn = 721,607
Nguyen et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials